BRIEF published on 06/02/2025 at 12:23, 1 year ago Gerresheimer Revises 2025 Financial Guidance Financial Guidance Dividend Proposal Gerresheimer AG Organic Revenue Growth Cosmetics Market
BRIEF published on 06/02/2025 at 12:23, 1 year ago Gerresheimer révise ses prévisions financières pour 2025 Gerresheimer AG Proposition De Dividende Croissance Organique Du Chiffre D'affaires Orientation Financière Marché Des Cosmétiques
PRESS RELEASE published on 06/02/2025 at 12:18, 1 year ago Gerresheimer Adjusts Guidance for Financial Year 2025 Gerresheimer adjusts guidance for 2025, citing subdued demand in the cosmetics market and temporary decline in demand for oral liquid medications. New 4% share capital dividend proposed Dividend Proposal Gerresheimer Organic Revenue Growth Guidance Adjustment 2025 Forecast
BRIEF published on 06/02/2025 at 11:45, 1 year ago Gerresheimer AG Revises 2025 Financial Guidance Gerresheimer AG Dividend Reduction Financial Update 2025 Guidance Adjustment Cosmetics Market Demand
BRIEF published on 06/02/2025 at 11:45, 1 year ago Gerresheimer AG révise ses prévisions financières pour 2025 Gerresheimer AG Mise À Jour Financière Réduction Des Dividendes Ajustement Des Prévisions Pour 2025 Demande Du Marché Des Cosmétiques
PRESS RELEASE published on 06/02/2025 at 11:40, 1 year ago EQS-Adhoc: Gerresheimer AG: Adjustment of Guidance for 2025 Gerresheimer AG adjusts its guidance for 2025 due to subdued demand in cosmetics and containment solutions for oral liquid medications. The company now expects lower organic revenue growth and adjusted margins Revenue Growth EBITDA Margin Gerresheimer AG Guidance Adjustment 2025 Forecast
BRIEF published on 05/12/2025 at 16:44, 1 year 1 month ago Gerresheimer Advances Sustainability with New Glass Production Facility Sustainability Investment Gerresheimer AG Glass Production Oxy-Hybrid Furnace
BRIEF published on 05/12/2025 at 16:44, 1 year 1 month ago Gerresheimer renforce sa stratégie de développement durable avec une nouvelle usine de production de verre Investissement Durabilité Gerresheimer AG Production De Verre Four Oxy-hybride
PRESS RELEASE published on 05/12/2025 at 16:39, 1 year 1 month ago Gerresheimer Successfully Completes Investment in State-of-the-Art Glass Production Facility in Lohr Gerresheimer completes EUR 100 million investment in modern glass production facility in Lohr, reducing CO2e emissions by 40% and enhancing sustainability Sustainability Investment Gerresheimer Glass Production Lohr
BRIEF published on 04/11/2025 at 07:05, 1 year 2 months ago Gerresheimer Reports Strong Q1 Growth Post-Bormioli Pharma Acquisition Revenue Growth Bormioli Pharma Gerresheimer Pharma Industry Q1 2025
Published on 06/29/2026 at 22:01, 58 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 7 hours 59 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 7 hours 59 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 8 hours 29 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 8 hours 29 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 22:47, 12 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 54 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 54 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 2 hours 29 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 2 hours 59 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 4 hours 29 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 4 hours 29 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 5 hours 14 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 5 hours 14 minutes ago Déclaration hebdomadaire de rachat d'actions
